Identification of the B subtype of γ-phospholipase A2 inhibitor from Protobothrops flavoviridis serum and molecular evolution of snake serum phospholipase A2 inhibitors

Journal of Molecular Evolution

Volumn 66, Issue 3, 2008, Pages 298-307

  So, Shuhei ^a   Chijiwa, Takahito ^a   Ikeda, Naoki ^a   Nobuhisa, Ikuo ^b   Oda Ueda, Naoko ^a   Hattori, Shosaku ^c   Ohno, Motonori ^a  

^a SOJO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Amino acid sequence; cDNA; Phospholipase A2 inhibitor; Phylogeny; Protobothrops flavoviridis; Three finger motif

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR;

AGKISTRODON; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; DNA LIBRARY; DRUG IDENTIFICATION; EVOLUTION; INTERNET; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN BLOOD LEVEL; SNAKE;

ANIMALS; BASE SEQUENCE; BOTHROPS; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME INHIBITORS; EVOLUTION, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASES A2; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID;

ACANTHOPHIINAE; COLUBRINAE; CROTALINAE; ELAPINAE; GLOYDIUS BLOMHOFFII SINITICUS; LATICAUDINAE; MAMMALIA; PYTHONIDAE; SERPENTES; TRIMERESURUS FLAVOVIRIDIS;

EID: 43149112782     PISSN: 00222844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00239-008-9089-1     Document Type: Article

References (57)

1. 2 at 2.5 Å. Access to a shielded catalytic center. J Biol Chem 260:9742-9749
2. Cadle JE (1987) Geographic distribution: problems in phylogeny and zoogeography. In: Seigel RA, Collins JT, Novak SS (eds) Snakes: ecology and evolutionary biology. Macmillan, New York, pp 77-105
3. Casey JR, Petranka JG, Kottra J, Fleenor DE, Rosse WF (1994) The structure of the urokinase-type plasminogen activator receptor gene. Blood 84:1151-1156
4. 2 isozymes. J Mol Evol 56:286-293
5. Cundall D, Wallach V, Rossman DA (1993) The systematic relationships of the snake genus Anomochilus. Zool J Linn Soc 109:275-299
6. 2 at 1.7 Å resolution. J Mol Biol 147:97-123
7. 2. J Mol Biol 168:163-179
8. 2 according to sequence. Evolutionary and pharmacological implications. Eur J Biochem 137:545-551
9. 2 enzymes. Biochim Biophys Acta 1533:29-37
10. Ernst CH, Zug GR, Griffin MD (1996) Snakes in question: the Smithsonian answer book. Smithsonian Institution Press, Washington, DC
11. Felsenstein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791
12. Fleming TJ, O'hUigin C, Malek TR (1993) Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins. J Immunol 150:5379-5390
13. 2 inhibitor from the plasma of the South American rattlesnake (Crotalus durissus terrificus). Protein structure, genomic structure, and mechanism of action. J Biol Chem 269:15646-15651
14. 2 inhibitor from Lachesis muta muta (the bushmaster snake). Toxicon 41:909-917
15. Fuse N, Tsuchiya T, Nonomura Y, Menez A, Tamiya T (1990) Structure of the snake short-chain neurotoxin, erabutoxin c, precursor gene. Eur J Biochem 193:629-633
16. 2 inhibitor from Notechis ater serum. J Biol Chem 275:983-991
17. 2 inhibitor from the serum of the common tiger snake (Notechis scutatus). J Mol Biol 312:875-884
18. Hattori M, Sakaki Y (1986) Dideoxy sequencing method using denatured plasmid templates. Anal Biochem 152:232-238
19. 2 from the venom of the cottonmouth snake at 2.0-Å resolution. J Biol Chem 265:17649-17656
20. 2 inhibitor from the blood plasma of Trimeresurus flavoviridis. J Biol Chem 266:1001-1007
21. Kawai J, Shinagawa A, Shibata K, Yoshino M, Itoh M, Ishii Y, Arakawa T, Hara A, Fukunishi Y, Konno H, Adachi J, Fukuda S, Aizawa K, Izawa M, Nishi K, Kiyosawa H, Kondo S, Yamanaka I, Saito T, Okazaki Y, Gojobori T, Bono H, Kasukawa T, Saito R, Kadota K, Matsuda H, Ashburner M, Batalov S, Casavant T, Fleischmann W, Gaasterland T, Gissi C, King B, Kochiwa H, Kuehl P, Lewis S, Matsuo Y, Nikaido I, Pesole G, Quackenbush J, Schriml LM, Staubli F, Suzuki R, Tomita M, Wagner L, Washio T, Sakai K, Okido T, Furuno M, Aono H, Baldarelli R, Barsh G, Blake J, Boffelli D, Bojunga N, Carninci P, de Bonaldo MF, Brownstein MJ, Bult C, Fletcher C, Fujita M, Gariboldi M, Gustincich S, Hill D, Hofmann M, Hume DA, Kamiya M, Lee NH, Lyons P, Marchionni L, Mashima J, Mazzarelli J, Mombaerts P, Nordone P, Ring B, Ringwald M, Rodriguez I, Sakamoto N, Sasaki H, Sato K, Schonbach C, Seya T, Shibata Y, Storch KF, Suzuki H, Toyo-oka K, Wang KH, Weitz C, Whittaker C, Wilming L, Wynshaw-Boris A, Yoshida K, Hasegawa Y, Kawaji H, Kohtsuki S, Hayashizaki Y, RIKEN Genome Exploration Research Group Phase II Team, the FANTOM Consortium (2001) Functional annotation of a full-length mouse cDNA collection. Nature 409:685-690
22. Kieffer B, Driscoll PC, Campbell ID, Willis AC, van der Merwe PA, Davis SJ, (1994) Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. Biochemistry 33:4471-4482
23. 2 inhibitor in habu serum. J Biochem (Tokyo) 80:341-349
24. 2. Biochem Int 28:895-903
25. Kimura M (1969) The rate of molecular evolution considered from the standpoint of population genetics. Proc Natl Acad Sci USA 63:1181-1188
26. 2 inhibitor from the blood plasma of Trimeresurus flavoviridis. J Biochem (Tokyo) 106:966-971
27. 2 with low activity, from Trimeresurus flavoviridis venom. J Biochem (Tokyo) 107:400-408
28. 2 myotoxins from its own venom: isolation, molecular cloning and biological properties. Biochem J 346:631-639
29. 2. J Biol Chem 261:4797-4804
30. 2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. J Biol Chem 259:13839-13843
31. 2 isozymes. Proc Natl Acad Sci USA 90:5964-5968
32. 2 isozyme genes. Proc Natl Acad Sci USA 92:5605-5609
33. Nei M, Li WH (1979) Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci USA 76:5269-5273
34. 2 inhibitors from the serum of Trimeresurus flavoviridis snake. Gene 191:31-37
35. 2 isozymes in the snake's venom. Eur J Biochem 249:838-845
36. 2 isozymes. FEBS Lett 429:385-389
37. 2, and consequent revision of the amino acid sequence. J Biochem (Tokyo) 108:816-821
38. 2 isozymes. Proc Natl Acad Sci USA 89:8557-8561
39. 2 inhibitor from the plasma of Thailand cobra having structural similarity to urokinase-type plasminogen activator receptor and LY-6 related proteins. Biochem Biophys Res Commun 204:1212-1218
40. 2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffi siniticus. Biochem J 325:527-531
41. 2 inhibitor from the blood plasma of the sea krait, Laticauda semifasciata. J Biochem (Tokyo) 125:375-382
42. Ohno M, Ménez R, Ogawa T, Danse JM, Shimohigshi Y, Fromen C, Ducancel F, Zinn-Justin S, Le Du MH, Boulain JC, Tamiya T, Ménez A (1998) Molecular evolution of snake toxins: is the functional diversity of snake toxins associated with a mechanism of accelerated evolution? Prog Nucleic Acid Res Mol Biol 59:307-364
43. Ohno M, Ogawa T, Oda-Ueda N, Chijiwa T, Hattori S (2002) Accelerated and regional evolution of snake venom gland isozymes. In: Ménez A (ed) Perspectives in molecular toxinology. John Wiley & Sons, New York, pp 387-400
44. 2 from snake venom. Toxicon 42:841-854
45. 2 inhibitor PLIgamma from blood plasma of the Chinese mamushi, Agkistrodon blomhoffi siniticus. IUBMB Life 48:99-104
46. Okumura K, Masui K, Inoue S, Ikeda K, Hayashi K (1999b) Purification, chracterization and cDNA cloning of a phospholipase A2 inhibitor from the serum of the nonvenomous snake Elaphe quadrivirgata. Biochem J 341:165-171
47. Petranka JG, Fleenor DE, Sykes K, Kaufman RE, Rosse WF (1992) Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein. Proc Natl Acad Sci USA 89:7876-7879
48. 2 from bovine pancreas and Crotalus atrox venom. J Biol Chem 260:11627-11634
49. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425
50. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467
51. Sekuloski S, Dunn RD, Broady KW (1999) AF211155-AF211168
52. Stone KL, Lopresti MB, Crawford JM, DeAngelis R, Williams KR (1989) Enzymatic digestion of proteins and HPLC peptide isolation. In: Matsudaira PT (ed) A practical guide to protein and peptide purification for microsequencing, Academic Press, New York, pp 33-47
53. 2 from Trimeresurus flavoviridis (Habu snake) venom at 1.5Å resolution. J Biochem (Tokyo) 117:730-740
54. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680
55. 2 inhibition and venom neutralizing potential. Biochemistry 39:9604-9611
56. Yamaguchi Y, Shimohigashi Y, Chijiwa T, Nakai M, Ogawa T, Hattori S, Ohno M (2001) Characterization, amino acid sequence and evolution of edema-inducing, basic phospholipae A2 from Trimeresurus flavoviridis venom. Toxicon 39:1069-1076
57. Yoshizumi K, Liu SY, Miyata T, Saita S, Ohno M, Iwanaga S, Kihara H (1990) Purification and amino acid sequence of basic protein I, a lysine-49-phospholipase A2 with low activity, from the venom of Trimeresurus flavoviridis (Habu snake). Toxicon 28:43-54